GlassScriptPhysician profile
Christopher D'Amico
NPI 1821585860
$11,110.58
in general payments reported to CMS, 2019-2025
36 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $311 · 2021: $885 · 2022: $4,127 · 2023: $2,412 · 2024: $1,832 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,677.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,774.48 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $1,239.18 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,181.99 | 2020-2025 | Repatha, Evenity, Prolia |
| Lilly USA, LLC | $1,073.52 | 2022-2025 | Mounjaro, Jardiance, Trulicity |
| Abbvie INC. | $975.82 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Abbott Laboratories | $503.50 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $446.41 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $415.85 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $402.19 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $399.00 | 2021-2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $394.94 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $348.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $308.25 | 2022-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $238.89 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $204.91 | 2021-2025 | Gardasil 9, Capvaxive, Pneumovax 23 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $185.39 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $142.25 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $118.71 | 2022-2023 | Airduo Digihaler |
| Scilex Pharmaceuticals INC. | $102.20 | 2022-2023 | Ztlido |
| Straumann USA LLC | $88.81 | 2025 | |
| Dynavax Technologies Corporation | $84.95 | 2021-2024 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $75.48 | 2023-2025 | |
| Nestle Healthcare Nutrition INC. | $59.11 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.30 | 2021-2024 | Jardiance |
| Alexion Pharmaceuticals, INC. | $42.07 | 2022-2025 | Strensiq |
| Astellas Pharma US INC | $41.81 | 2025 | Veozah |
| Dexcom, INC. | $41.70 | 2024-2025 | Dexcom G6 Transmitter |
| Abiomed | $32.82 | 2025 | |
| Agios Pharmaceuticals, INC. | $23.87 | 2022 | |
| Genentech USA, INC. | $22.77 | 2022 | |
| Radius Health, INC. | $19.21 | 2025 | Tymlos |
| Esperion Therapeutics, INC. | $17.27 | 2021 | |
| Echosens North America, INC. | $17.05 | 2025 | Fibroscan |
| Xeris Pharmaceuticals, INC. | $13.84 | 2022 | |
| Optinose US, INC. | $13.73 | 2021 | |
| Sanofi Pasteur INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher D'Amico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.